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ABSTRACT  
Extracellular matrix is a key regulator of normal homeostasis and tissue phenotype1. These 
signals are lost when cells are cultured ex vivo on two dimensional (2D) plastic substrata. Many 
of these crucial microenvironmental cues may be restored using three dimensional (3D) cultures 
of laminin-rich extracellular matrix (lrECM)2. 3D culture assays enable phenotypic 
discrimination between non-malignant and malignant mammary cells, as the former grown in a 
3D context form polarized, growth-arrested acinus-like colonies while the latter form 
disorganized, proliferative and non-polar colonies3. Signaling pathways which function in 
parallel in cells cultured on plastic become reciprocally integrated when the cells are exposed to 
basement membrane-like gels4-7. Appropriate 3D culture thus provides a more physiologically 
relevant approach to the analysis of gene function and cell phenotype ex vivo. We describe here a 
robust and generalized method for the culturing of various human breast cell lines in 3D and 
describe the preparation of cellular extracts from these cultures for molecular analyses. 
 
MATERIALS 
REAGENTS  
• Engelbreth-Holm-Swarm extracellular matrix extract (EHS), growth factor-reduced (MatrigelTM, BD 
Biosciences; Cultrex® BME, Trevigen) 
• Hard-set mounting medium (VECTASHIELD HardSet, Vector Laboratories; ProLong Gold, Invitrogen)  
• Immunofluorescence (IF) buffer: 0.2% Triton-X 100, 0.1% BSA (RIA grade), 0.05% Tween 20 in PBS (pH 
7.4; sterilized, 0.22 μm filter); if long term storage is desired, add 7.7 mM NaN3 
• IF blocking solution: 10% goat serum, 1% goat F(ab’)2 anti-mouse IgG (Caltag) in IF buffer 
• Phosphate-buffered saline (PBS): 130 mM NaCl, 13 mM Na2HPO4, 3.5 mM NaH2PO4 
• PBS/EDTA: 5 mM EDTA, 1 mM NaVO4, 1.5 mM NaF in PBS 
• PBS/glycine: 100 mM glycine in PBS  
 
PROCEDURE 
 
Margin heading: Culturing cells in 3D 
We utilize the term “3D culture” to refer to the culture of cells in the presence of a laminin-rich 
extracellular matrix (lrECM), in particular, the solubilized extract derived from the Engelbreth-
Holm-Swarm mouse sarcoma (EHS)8. For a discussion of user options regarding 3D matrices, 
see Box 1. The procedure below describes the 3D “embedded” assay, in which cells are cultured 
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embedded in an lrECM gel9 (Fig. 1). Alternatively, the 3D “on-top” assay, in which cells are 
cultured on top of a thin lrECM gel overlaid with a dilute solution of lrECM, may be used as 
described in Box 2 (Figs. 1 and 2). 
1. Thaw EHS at 4°C overnight.  
2. Coat pre-chilled culture surface (e.g. dish or well) with a thin layer of EHS. Slowly pipette the 
appropriate volume (Table 1) directly onto surface and spread evenly with a pipette tip or 
plunger of a 1 ml syringe for smaller areas or cell lifter for larger areas. Incubate for 15 to 30 min 
at 37°C to allow the EHS to gel (but do not let it overdry). 
CRITICAL STEP 
3. Trypsinize cells from a monolayer to a single cell suspension. 
Use cells that are healthy and not more than 75% confluent. 
TROUBLESHOOTING 
4. Aliquot cells to be plated into a 1.5 ml microcentrifuge tube. Gently pellet the cells by 
centrifugation at ~115g and, on ice, resuspend the cells into the appropriate volume of EHS 
(Table 1). 
The number of cells to be plated per ml of EHS will depend on the growth properties of the cell 
line and may need some optimization, but we recommend the following ranges: for non-
malignant cells, 0.85 x 106 cells/ml; for malignant cells, 0.50 - 0.60 x 106 cells/ml. 
CRITICAL STEP 
5. Pipette the mixture of cells and EHS onto the pre-coated surface. Incubate 30 min at 37°C to 
allow EHS to gel. Add appropriate volume of cell line-appropriate medium (Table 1). 
TROUBLESHOOTING 
6. Maintain culture for 10 days, changing medium every 2 days. 
7. To perform drug response assays in 3D, see Box 3.  
 
Margin heading: Extracting cells from 3D cultures 
8. Colonies may be fully extracted from their 3D culture environment for further analyses, e.g. 
immunostaining, DNA, RNA and protein extraction (Option A, Complete extraction). If only an 
immunostaining endpoint is desired, a complete extraction is often not necessary. An abbreviated 
procedure may be performed in which the gel is partially broken down, allowing for sufficient 
dissolution of polymerized EHS in the sample for immunostaining (Option B, In-well 
3D culture models of normal and malignant breast epithelial cells; Lee et al. 
 4
extraction). Alternatively, colonies may be fixed and then immunostained directly in the gel 
(Option C, Whole culture fixation; proceeding to Box 4, Whole culture immunostaining). This 
latter method is generally only preferable if a 3D colony you would like to visualize would be 
disrupted by extraction (as in Fig. 2c) as the immunostaining procedure then requires a much 
larger amount of antibody per sample and is less flexible since a single culture may only be 
stained against one set of markers. If only RNA extraction is desired, the culture may be directly 
solubilized by addition of Trizol. 
 
Option A Complete extraction  
Perform all steps on ice. 
a. Aspirate media, rinse 2X with 1 [media] volume ice-cold PBS. 
b. Add 2-3 volumes cold PBS/EDTA. Detach EHS from the bottom of culture 
surface using a cell lifter (for dishes of diameter ≥ 35 mm) or by gently 
scraping the bottom with a pipette tip. Shake gently for 15-30 min. 
3D embedded cultures will require a larger volume of PBS/EDTA than 3D on-
top cultures and will also take longer to break down.  
c. Transfer solution to a conical tube. Rinse culture surface once with 0.5 
volume PBS/EDTA, transferring the rinse also to the tube. Gently shake tube 
on ice for 15-30 min. 
d. Inspect tube to check that EHS has dissolved completely (invert tube gently 
and look for a homogeneous suspension of cell colonies without visible EHS 
gel fragments). 
If not, wait longer and/or add additional PBS/EDTA.  
e. To collect colonies for immunostaining, follow these steps. Otherwise, skip 
ahead to (f).  
i. Centrifuge at ~115g for 1-2 minutes such that cell colonies collect at 
the bottom of the tube but do not form a tight pellet. 
CRITICAL STEP 
ii. Carefully aspirate the majority of the supernatant. Gently resuspend 
the colonies. Pipette approximately 15 µl of the colony suspension 
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onto a slide and fix, using an fixative appropriate for the antigen of 
interest. 
CRITICAL STEP 
PAUSE POINT Colonies fixed on slides may be stored at -20°C for 
several months.  
f. Centrifuge the colonies into a pellet. Aspirate supernatant and lyse with 
appropriate extraction buffer and process using standard procedures10. 
For protein extraction an additional wash with PBS/EDTA will minimize the 
amount of EHS in the final extract.  
PAUSE POINT Extracts may be stored at -80°C for several months.  
 
Option B In-well extraction 
Perform all steps on ice. 
a. Follow Option A [a-b] 
b. Check under microscope to verify that majority of EHS has broken apart and 
colonies have settled to bottom of the well 
If not, wait longer and/or add an additional volume PBS/EDTA.  
c. Carefully aspirate the majority of the supernatant. Pipette approximately 15µl 
of the colonies in solution onto a slide and fix. 
CRITICAL STEP 
PAUSE POINT Cultures fixed on slides may be stored at -20°C for several 
months.  
 
Option C Whole culture fixation  
Perform all steps on ice. 
a. Aspirate media, rinse 2X with 1 [media] volume ice-cold PBS. 
b. Fix culture with 4% paraformaldehyde at room temperature for 10 minutes. 
c. Stop fixation with PBS/glycine for 10 minutes; wash once and store in PBS. 
PAUSE POINT Fixed cultures may be stored at 4°C for up to 4 days.  
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Margin heading: Immunostaining of 3D cultures 
9. This immunostaining procedure applies to cultures fixed on slides generated by Options A or 
B (Figs. 2a, 2b and 3) but may also be applied to the immunostaining of fixed whole cultures 
generated by Option C (see Box 4, Whole culture immunostaining; Fig. 2c).  
10. Wash slides: PBS/glycine, 3X 10 min, room temperature (RT).  
11. Block slides: IF blocking solution, 1.5h, RT in moist chamber. 
The anti-mouse F(ab’)2 fragments in the IF blocking solution block against immunoreactive 
mouse IgG species in EHS. 100 μl of blocking solution spread with a strip of Parafilm is 
sufficient volume for incubation. 
12. Primary antibody staining: Primary antibody of interest diluted in IF buffer, 2h, RT in humid 
chamber.  
13. Wash slides: IF buffer, 3X 20 min, RT. 
14. Secondary antibody staining: Secondary antibody diluted in IF buffer, 45 min, RT in humid 
chamber. 
15. Wash slides: IF buffer, 1X 20 min; PBS 2X 10 min, RT. 
16. Nuclear counterstain: DAPI (0.5 μg/ml), 5 min, RT. 
17. Wash slides: PBS, 10 min, RT. 
18. Mount slides: Spread one drop of hard-set mounting medium with a No. 1 ½ coverslip and 
allow to set overnight at 4°C. 
Take care to avoid forming bubbles when mounting to minimize photobleaching. 
PAUSE POINT Mounted slides may be stored at -20°C for several months. 
19. Due to the thickness of the samples, confocal microscopy is ideal for imaging of 3D cultures. 
 
 
TROUBLESHOOTING TABLE 
 
PROBLEM SOLUTION 
Step 5 Cells are not suspended and have 
settled to the bottom of the EHS gel  
If the cell/EHS mixture in Step 4 is diluted with 
medium prior to setting, the cells may settle to the 
bottom of the gel. Be sure to aspirate the majority 
of the supernatant to avoid this problem.  
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Step 19 Excess EHS causes 
immunostaining background. 
Colonies fully extracted from the EHS gel as in 
Option A should have little or no background. 
Partial extraction of colonies by Option B may 
result in background if EHS is not sufficiently 
broken down, and a haze or cloud of EHS adheres 
to cells. To avoid this, increase both the volume 
of PBS/EDTA used and the incubation time. 
Box 2 Step 4 After plating, cells are not 
resting singly on the layer of EHS but have 
aggregated together in clumps and/or are 
concentrated in the center of the well. 
Cells of some lines tend to aggregate with one 
another and may not adhere as quickly to the 
EHS. In Step 4, agitation of the plate in the xy 
plane at intervals during incubation at 37°C may 
assist with preventing cell concentration in the 
center of the well (do not apply a swirling motion 
as cells will then accumulate around the edge of 
the well). 
 
 
CRITICAL STEPS 
Step 2 Culture surfaces must be pre-chilled and coated on ice to ensure even spreading of EHS. 
Pipette EHS slowly and directly onto culture surface to avoid formation of bubbles which may 
allow cells to come in direct contact with the culture surface and begin to spread as a monolayer 
beneath the gel. 
Step 4 After aspiration of the supernatant, gently flick the tube to loosen the cell pellet so that 
when EHS is added, the cells are in a single cell suspension. Pipette carefully when mixing to 
avoid bubbles. 
Step 8, Option A (e, i) Centrifugation time will depend on the size of your colonies and may 
require some optimization. Larger colonies will settle on their own and may only require a pulse 
to collect at the bottom of the tube whereas smaller colonies may have only just collected in the 
conical area of the tube after 2 minutes of centrifugation. 
Step 8, Option A (e, ii); Option B (c) The amount of aspiration required to achieve the balance 
between getting a high number of colonies on the slide in a relatively low volume of liquid may 
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require some practice. If the volume of liquid used to pipette a sufficient number of colonies is 
too high it may decrease the efficiency of fixation. The slides may sit for some time to allow 
excess liquid to evaporate but do not allow the cells to dry out completely at any point as this 
will alter their structure. 
 
 
BOX 1 EHS user’s guide 
EHS is available commercially from a number of sources, including BD Biosciences (Matrigel™) 
and Trevigen (Cultrex® Basement Membrane Extract). EHS can also be prepared directly from 
EHS tumors grown as xenografts11. As EHS is a biological product, its components and 
properties, including ECM protein and growth factor concentrations, endotoxin levels and 
stiffness, vary between lots. It is therefore desirable to perform a series of experiments using the 
same lot number to minimize variation introduced by slight differences in the properties of the 
EHS. It is also important, when a new lot is obtained, to test whether it is appropriate for culture 
by performing a side-by-side comparison with cells grown in EHS from the former lot. We 
routinely evaluate new lots for the typical and appropriate morphogenesis of non-malignant and 
malignant cells along with the expression of a number of markers of interest. We also 
exclusively use growth factor-reduced EHS since much of our work is in the absence of serum 
and under defined medium conditions. Depending on the nature of the cell type and parameters 
to be measured, you may develop your own strategy for validation and arrive at your own EHS 
preferences.  
 
BOX 2 3D on-top assay 
As an alternative to the 3D embedded assay, we developed the 3D on-top assay which requires a 
shorter amount of time, a decreased amount of EHS, and facilitates imaging, since colonies are in 
a single plane. Therefore, the on-top assay is ideal for time-lapse imaging and also for in situ 
immunostaining of cell lines which form invasive stellate structures in 3D (see Step 8, Option 
C). Because less EHS is required, it is also a more cost-effective approach.  
1. Thaw EHS at 4°C overnight. 
2. Coat pre-chilled culture surface (e.g. dish or well) with a layer of EHS. Slowly pipette the 
appropriate volume (Table 1) directly onto surface and spread evenly with a pipette tip or 
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plunger of a 1 ml syringe for smaller areas or cell lifter for larger areas. Incubate for 30 min at 
37°C to allow the EHS to gel (but do not let it overdry). 
Culture surfaces must be pre-chilled and coated on ice to ensure even spreading of EHS. Pipette 
EHS slowly and directly onto culture surface to avoid formation of bubbles. 
3. Trypsinize cells from a monolayer to a single cell suspension. 
Use cells that are healthy and not more than 75% confluent. 
4. Plate cells in half the final specified volume of cell line-appropriate medium (Table 1) onto 
the coated surface. Allow the cells to settle and attach to the EHS for 10-30 min at 37°C. 
The number of cells to be plated per cm2 of EHS surface area may need some optimization 
depending on the growth properties of the cell line, but we recommend the following ranges: for 
non-malignant cells, 0.25 x 105 cells/cm2; for malignant cells, 0.175 - 0.20 x 105 cells/cm2. 
TROUBLESHOOTING 
5. Chill remaining half volume of medium and add EHS to 10%. Gently add the EHS/medium 
mixture to the culture.  
Medium must be thoroughly chilled before addition of EHS to ensure homogenous mixing and 
even deposition of EHS onto cells in culture. Pipette the drip down the side of the well to avoid 
disturbance of the cells or EHS gel. 
6. Maintain culture for 4 days, replacing EHS/medium mixture every 2 days. 
7. To perform drug response assays in 3D, see Box 3. 
 
BOX 3 Drug response assays  
To perform drug response assays in 3D embedded or 3D on-top cultures7, 12, 13 (Fig. 3 and 
Supplementary Videos 1 [vehicle] and 2 [EGFR inhibitor, AG1478]), compounds may be 
added to the culture in one of two manners depending on their compositions: 
1. Small molecule inhibitors: add to medium when cells are plated in Step 5 of the main protocol 
and the 3D on-top protocol (Box 2). Include compound in all media changes for the duration of 
the culture. 
2. Blocking antibodies: mix with cells before plating in Step 4 of the main protocol and the 3D 
on-top protocol (Box 2). Include antibody in all media changes for the duration of the culture. 
 
BOX 4 Whole culture immunostaining 
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When performing whole culture immunostaining in a well, the general procedure for 
immunostaining may be applied (see Steps 9 - 19), with some slight modifications:   
a. Washes are performed in the well and require careful pipetting and aspiration; 
if cultures are not treated gently, colonies may detach from the EHS and be 
lost. It is advisable to check cultures frequently under a microscope to ensure 
they are still attached. 2X media volume is suggested for washes; for antibody 
incubations, 0.5X volume is sufficient. 
b. Samples immunostained in a chamberslide may be mounted directly after 
removal of the chamber and aspiration of excess fluid. 
c. Samples immunostained in a tissue culture well should be removed and 
mounted on a slide for long-term storage and higher quality imaging. 
 
 
COMMENTS 
We describe here a generalized protocol for monotypic 3D breast epithelial cell culture in the 
presence of lrECM, an approach which has proved to be extremely informative in our laboratory 
and those of others. Other workers have succeeded in culturing cell types from a wide variety of 
tissues using these techniques, summarized in14. While much of this work has been performed 
using EHS, other 3D substrata, such as collagen I gels, are excellent for assays of mammary 
gland branching morphogenesis15, and we are watching with interest the development of 
additional synthetic and natural 3D substrata. Using these approaches, we hope to develop 
functional organotypic cultures comprised of multiple cell types, including epithelial, 
myoepithelial, stromal and endothelial for experimental manipulation within full context of a 
complex breast tissue. 
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TABLE 1 Suggested volumes for 3D culture 
 
  
  3D embedded 3D on-top 
  
# 
Well 
Diameter 
(mm) 
Area 
(cm2) 
Medium 
volume (µl) 
EHS coat 
(μl) 
EHS plate 
(μl) EHS coat (μl) 
Dish -- 60 19.5 5000 250 3600 850 
6 35 9.6 2000 120 1200 500 
24 16 2.0 500 50 300 120 
48 10 0.75 200 30 150 80 
Plates 
96 6 0.26 60 5 75 15 
4 -- 1.8 500 50 300 120 Chamber-
slides 8 -- 0.8 200 30 150 90 
 
Note that the volumes of EHS to be plated are not directly proportional to surface area. The 
viscosity of EHS causes it to form a meniscus in the well, the effect of which increases with 
decreasing well size. As a corollary, for 3D on-top cultures, the smaller the well size, the less flat 
the plane of plating will be. 
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FIGURE LEGENDS 
 
Figure 1 Breast epithelial cell morphology in differing culture conditions. (a) Schematic of non-
malignant breast epithelial cells grown as a monolayer on tissue culture plastic (left), in the 3D 
embedded assay (middle), and in the 3D on-top assay (right). (b) Phase contrast images of (top) 
non-malignant HMT-3522 S1 cells grown in the 3 different culture conditions and (bottom) 
malignant HMT-3522 T4-2 cells grown in the same conditions. Scale bar, 50 μm. 
 
Figure 2 Breast cancer cell lines in 3D culture. Phase contrast images (left panel) and confocal 
cross-sections of Phalloidin staining of F-actin (right panel) of (a) BT474; (b) SKBR3; and (c) 
MDA-MB 231 cell lines grown for 4 days in the 3D on-top assay. In (a) and (b), colonies were 
completely extracted from the gel for immunostaining; in (c), colonies were immunostained in 
the gel. Scale bars, 100 μm (left panel) and 50 μm (right panel). 
 
Figure 3 3D drug response assay. HMT-3522 S1 (a), HMT-3522 T4-2 (b), and HMT-3522 T4-2 
treated with an EGFR inhibitor, AG1478 (c) were cultured in the 3D on-top assay for 4 days. 
Colonies were then extracted and immunostained against α6 integrin (green) and β-catenin (red). 
Nuclei were counterstained with DAPI (blue). Confocal sections through the centers of the 
colonies are shown. Scale bar, 20 μm. 
 
Supplemental Video 1 Time lapse movies of HMT-3522 T4-2 cells treated with vehicle and 
cultured in the 3D on-top assay for 4 days. Phase contrast images were taken at 1 hour intervals. 
 
Supplemental Video 2 Time lapse movies of HMT-3522 T4-2 cells treated with an EGFR 
inhibitor, AG1478, and cultured in the 3D on-top assay for 4 days. Phase contrast images were 
taken at 1 hour intervals. 
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